tiprankstipranks
Trending News
More News >
Human Creation Holdings, Inc. (JP:7361)
:7361
Japanese Market

Human Creation Holdings, Inc. (7361) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7361

Human Creation Holdings, Inc.

(7361)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 4o)
Rating:79Outperform
Price Target:
¥1,477.00
▲(8.68% Upside)
Human Creation Holdings, Inc. demonstrates strong financial performance and attractive valuation, which are the primary drivers of the stock's score. The technical analysis supports a positive outlook with bullish momentum. The absence of earnings call data and corporate events does not detract from the overall positive assessment.
Positive Factors
Revenue Growth
The company's consistent revenue growth indicates a strong market position and effective business model, supporting long-term expansion.
Cash Flow Management
Robust cash flow management enhances financial flexibility, enabling strategic investments and resilience against economic fluctuations.
Profitability Margins
Strong profitability margins reflect efficient operations and cost management, which are crucial for sustaining competitive advantage.
Negative Factors
Rising Debt Levels
Increasing debt levels may strain financial resources, potentially impacting future growth and operational flexibility.
Net Income Decline
A decline in net income suggests potential inefficiencies or increased costs, which could hinder long-term profitability.
Leverage Concerns
Moderate leverage requires careful management to avoid financial strain, especially in volatile market conditions.

Human Creation Holdings, Inc. (7361) vs. iShares MSCI Japan ETF (EWJ)

Human Creation Holdings, Inc. Business Overview & Revenue Model

Company DescriptionHuman Creation Holdings, Inc., through its subsidiaries, operates in the information technology (IT) industry. The company engages in the system design/development, IT technology consultant, and network/server design, as well as construction, management, and operation activities; and system consultation and hardware design/development activities. It also provides consulting services in the areas of business and organizational reform, IT strategy, and solution selection; technology consulting services comprising requirements analysis, project management, and solution introduction support; and ICT-related help desk management, education, manual production/planning and operation of showrooms, service centers, etc.; and outsourcing services for government. In addition, the company dispatches engineers. Human Creation Holdings, Inc. was founded in 1974 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyHuman Creation Holdings, Inc. generates revenue through multiple key streams, primarily from the sale of its medical technologies and devices to healthcare providers, hospitals, and clinics. Additionally, the company earns income from licensing its proprietary technologies to other firms in the healthcare sector. Strategic partnerships with research institutions and pharmaceutical companies also contribute to its revenue, as collaborative projects often lead to shared profits from new product developments. Furthermore, the company is involved in offering subscription-based health management services, which provide ongoing revenue through recurring fees. These diverse revenue streams ensure a robust financial model while enabling the company to capitalize on growth opportunities in the evolving healthcare landscape.

Human Creation Holdings, Inc. Financial Statement Overview

Summary
Human Creation Holdings, Inc. exhibits strong financial performance with consistent revenue growth and solid profitability margins. The balance sheet is stable, though the increase in debt warrants monitoring. Cash flow generation is robust, supporting the company's financial flexibility.
Income Statement
85
Very Positive
Human Creation Holdings, Inc. has demonstrated strong revenue growth with a 9.09% increase in the latest year. The company maintains healthy profitability margins, with a gross profit margin of 30.37% and a net profit margin of 4.45%. The EBIT and EBITDA margins are also solid at 8.74% and 9.69%, respectively, indicating efficient operational management. However, the slight decline in net income compared to the previous year suggests potential areas for cost optimization.
Balance Sheet
78
Positive
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.75, indicating moderate leverage. The return on equity is robust at 26.04%, showcasing effective use of shareholder funds. The equity ratio stands at 34.04%, suggesting a balanced capital structure. However, the increase in total debt over the year could pose a risk if not managed carefully.
Cash Flow
82
Very Positive
The company has shown impressive cash flow management with a significant increase in operating cash flow. The operating cash flow to net income ratio is strong at 2.58, indicating efficient cash generation relative to net income. The free cash flow to net income ratio is also favorable at 2.57, highlighting the company's ability to generate cash after capital expenditures. The positive free cash flow growth rate of 115.66% further underscores the company's strong cash flow position.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue8.20B8.95B7.17B6.49B5.80B5.04B
Gross Profit2.39B2.72B2.08B1.96B1.77B1.43B
EBITDA793.11M867.23M755.55M822.20M663.73M545.43M
Net Income379.62M398.48M404.03M438.43M343.00M275.89M
Balance Sheet
Total Assets4.36B4.50B2.98B2.96B2.54B2.19B
Cash, Cash Equivalents and Short-Term Investments1.16B1.42B1.00B1.02B672.86M846.22M
Total Debt1.32B1.14B375.84M641.34M546.01M266.42M
Total Liabilities2.95B2.97B1.63B1.90B1.62B1.13B
Stockholders Equity1.41B1.53B1.35B1.06B915.76M1.06B
Cash Flow
Free Cash Flow0.001.02B474.16M705.49M370.36M256.61M
Operating Cash Flow0.001.03B481.45M722.94M373.48M267.53M
Investing Cash Flow0.00-896.35M-3.11M-169.25M-335.00M-51.74M
Financing Cash Flow0.00281.51M-495.91M-206.47M-211.84M44.41M

Human Creation Holdings, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1359.00
Price Trends
50DMA
1339.68
Positive
100DMA
1256.43
Positive
200DMA
1197.07
Positive
Market Momentum
MACD
13.69
Positive
RSI
51.79
Neutral
STOCH
19.70
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7361, the sentiment is Positive. The current price of 1359 is below the 20-day moving average (MA) of 1395.80, above the 50-day MA of 1339.68, and above the 200-day MA of 1197.07, indicating a neutral trend. The MACD of 13.69 indicates Positive momentum. The RSI at 51.79 is Neutral, neither overbought nor oversold. The STOCH value of 19.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7361.

Human Creation Holdings, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥4.53B10.922.09%24.84%2.56%
76
Outperform
¥7.04B18.111.32%12.73%
66
Neutral
¥2.90B25.348.11%255.15%
66
Neutral
¥4.66B-89.873.66%13.47%-108.63%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
59
Neutral
¥3.52B37.815.06%37.14%
43
Neutral
¥2.08B-13.812.66%-10.61%-160.10%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7361
Human Creation Holdings, Inc.
1,375.00
360.09
35.48%
JP:4766
PA Co., Ltd.
270.00
43.50
19.21%
JP:6198
CAREER CO., LTD.
244.00
-91.00
-27.16%
JP:6538
CareerIndex, Inc.
337.00
199.21
144.58%
JP:6563
Mirai Works, Inc.
649.00
-323.00
-33.23%
JP:9344
Axis Consulting Corporation
921.00
-6.35
-0.68%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025